HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Pecorelli Selected Research

Papillary Adenocarcinoma

9/2010hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma.
1/2010In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Pecorelli Research Topics

Disease

24Neoplasms (Cancer)
01/2017 - 01/2000
19Ovarian Neoplasms (Ovarian Cancer)
07/2013 - 03/2000
8Carcinoma (Carcinomatosis)
07/2013 - 01/2000
8Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2006 - 01/2000
5Endometrial Neoplasms (Endometrial Cancer)
09/2008 - 01/2000
4Ovarian Epithelial Carcinoma
10/2012 - 05/2000
3Papillary Carcinoma
09/2010 - 05/2004
3Adenocarcinoma
11/2008 - 01/2000
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2001 - 06/2000
2Papillary Adenocarcinoma
09/2010 - 01/2010
2Thrombocytopenia (Thrombopenia)
03/2003 - 03/2000
1Vesico-Ureteral Reflux (Vesicoureteral Reflux)
01/2024
1Urinary Tract Infections (Urinary Tract Infection)
01/2024
1Vaginal Diseases
01/2017
1Frailty
01/2017
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2017
1Preterm Premature Rupture of the Membranes
01/2011
1Sarcoma (Soft Tissue Sarcoma)
04/2008
1Lung Neoplasms (Lung Cancer)
11/2003
1Carcinosarcoma
03/2003
1Anemia
01/2003
1Neoplasm Metastasis (Metastasis)
09/2001
1Hypersensitivity (Allergy)
09/2001
1Alopecia (Baldness)
09/2001
1Vulvar Neoplasms (Vulvar Cancer)
06/2001

Drug/Important Bio-Agent (IBA)

9Cisplatin (Platino)FDA LinkGeneric
11/2003 - 01/2000
7PlatinumIBA
10/2012 - 03/2000
5Biomarkers (Surrogate Marker)IBA
10/2012 - 09/2008
4AntigensIBA
07/2013 - 03/2001
4Proteins (Proteins, Gene)FDA Link
04/2012 - 09/2008
4Paclitaxel (Taxol)FDA LinkGeneric
11/2003 - 03/2000
3Trastuzumab (Herceptin)FDA Link
04/2012 - 01/2010
3Neoplasm Antigens (Tumor Antigens)IBA
01/2004 - 09/2000
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2003 - 05/2000
3CytokinesIBA
08/2001 - 09/2000
3Monoclonal AntibodiesIBA
03/2001 - 09/2000
2Mammaglobin BIBA
07/2013 - 09/2008
21-oleoyl-2-stearoylphosphatidylcholineIBA
07/2013 - 05/2004
2Messenger RNA (mRNA)IBA
11/2008 - 09/2008
2Oncogene Proteins (Oncogene Protein)IBA
10/2006 - 03/2001
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2004 - 09/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2003 - 01/2001
2Mitomycin (Mitomycin-C)FDA LinkGeneric
09/2001 - 06/2000
2Transforming Growth Factor beta (TGF-beta)IBA
08/2001 - 05/2000
2Interleukin-10 (Interleukin 10)IBA
08/2001 - 05/2000
2Bleomycin (Blenoxane)FDA LinkGeneric
06/2001 - 06/2000
2HLA-DR Antigens (HLA-DR)IBA
06/2001 - 01/2001
2Interferon-gamma (Interferon, gamma)IBA
09/2000 - 05/2000
2Oxyquinoline (8 Hydroxyquinoline)FDA Link
01/2000 - 01/2000
1CreatinineIBA
01/2024
1Succimer (Dimercaptosuccinic Acid)FDA Link
01/2024
1Papillomavirus Vaccines (HPV Vaccines)IBA
01/2017
1VaccinesIBA
01/2017
1MicroRNAs (MicroRNA)IBA
10/2012
13' Untranslated Regions (3' UTR)IBA
10/2012
1Complement Inactivating AgentsIBA
04/2012
1Complement System Proteins (Complement)IBA
04/2012
1Small Interfering RNA (siRNA)IBA
04/2012
1Epidermal Growth Factor (EGF)IBA
10/2011
1A-factor (Streptomyces)IBA
09/2010
1hI-con1IBA
09/2010
1Rituximab (Mabthera)FDA Link
09/2010
1Thromboplastin (Tissue Factor)IBA
09/2010
1Taxoids (Taxanes)IBA
04/2010
1ST 1481 (Gimatecan)IBA
04/2010
1pertuzumabIBA
01/2010
1Serum Amyloid A Protein (Serum Amyloid A)IBA
07/2009
1Tight Junction ProteinsIBA
11/2008
1Trefoil Factor-3IBA
09/2008
1UteroglobinIBA
09/2008
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
11/2003
1IfosfamideFDA LinkGeneric
03/2003
1Serine Proteases (Serine Protease)IBA
04/2002
1Methotrexate (Mexate)FDA LinkGeneric
06/2001
1Lomustine (CCNU)FDA Link
06/2001
1PerforinIBA
03/2001
1AcidsIBA
09/2000
1Histocompatibility Antigens Class IIBA
09/2000
1Peptides (Polypeptides)IBA
09/2000
1ChromiumIBA
09/2000
1Concanavalin AIBA
09/2000
1Vindesine (Vindesin)IBA
06/2000

Therapy/Procedure

12Drug Therapy (Chemotherapy)
07/2013 - 01/2000
8Immunotherapy
07/2013 - 01/2000
7Therapeutics
10/2012 - 05/2000
3Radiotherapy
04/2008 - 11/2000
3Combination Drug Therapy (Combination Chemotherapy)
09/2001 - 01/2001
2TP protocol
11/2003 - 05/2000
2Gamma Cameras (Gamma Camera)
01/2000 - 01/2000
1Polypharmacy
01/2017
1Treatment Delay
01/2011
1Adjuvant Radiotherapy
04/2008
1Adjuvant Chemotherapy
11/2003
1Drug Tapering
03/2003
1Hysterectomy
01/2003
1Salpingo-oophorectomy
01/2003
1Brachytherapy
01/2003
1Blood Transfusion (Blood Transfusions)
01/2003
1Palliative Care (Palliative Therapy)
06/2001
1Vulvectomy
06/2001